Evaluation of solid dispersion particles prepared with SEDS.

Int J Pharm

AstraZeneca R&D Mölndal, S-431 83, Mölndal, Sweden.

Published: January 2003

Formation of solid solution particles in the Solution Enhanced Dispersion by Supercritical fluids (SEDS) process from a model drug and two different types of carriers, mannitol and Eudragit E100 was evaluated. The crystal properties of samples and molecular interactions were investigated with DSC and FTIR, respectively. The effect of co-crystallisation of drug and mannitol on dissolution rate was studied. Even if a true one-phase solid dispersion was not obtained, the crystal structure of both drug and mannitol was mutually affected by the presence of the other. The drug was not in highly crystalline form in the co-precipitates. The interactions between the drug and mannitol could also be identified as hydrogen bonding between the amine or hydroxyl groups of the drug and the hydroxyl groups of mannitol. These interactions and changes in the crystal structure are probably directly related to the increase in the dissolution rate observed. A true solid solution was obtained when the drug was co-processed with Eudragit E100. A clear interaction between the acid hydroxyl group of the drug and the basic carbonyl group on the Eudragit E100 was observed. SEDS was shown to be an effective process for forming intimate blends and solid solutions for the drug and two different types of carriers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0378-5173(02)00577-xDOI Listing

Publication Analysis

Top Keywords

eudragit e100
12
drug mannitol
12
drug
9
solid dispersion
8
solid solution
8
drug types
8
types carriers
8
dissolution rate
8
crystal structure
8
hydroxyl groups
8

Similar Publications

Solution-mediated phase transformation of cocrystals at the solid-liquid interface: Relationships between the supersaturation generation rate and transformation pathway.

Int J Pharm

January 2025

State Key Laboratory of Natural Medicines, Department of Pharmaceutics, Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing 211198, China. Electronic address:

Cocrystals easily undergo solution-mediated phase transformation at the surface of dissolving cocrystals during dissolution, which significantly deteriorates the solubility advantage of cocrystals. Here, a new scenario for the phase transformation of liquiritigenin (LQ) cocrystals in which the boundary of phase transformation diffuses along the surface to the bulk of the cocrystal was identified. Additionally, depending on the rate of supersaturation generation, phase transformation processes to the anhydrate and hydrate of LQ compete during cocrystal dissolution.

View Article and Find Full Text PDF

Electrospun Amorphous Solid Dispersions with Lopinavir and Ritonavir for Improved Solubility and Dissolution Rate.

Nanomaterials (Basel)

September 2024

Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.

Lopinavir (LPV) and ritonavir (RTV) are two of the essential antiretroviral active pharmaceutical ingredients (APIs) characterized by poor solubility. Hence, attempts have been made to improve both their solubility and dissolution rate. One of the most effective approaches used for this purpose is to prepare amorphous solid dispersions (ASDs).

View Article and Find Full Text PDF

Clarithromycin (CLA) is the preferred drug for treating respiratory infections in pediatric patients, but it has the drawbacks of extreme bitterness and poor water solubility. The purpose of this study was to improve solubility and mask the extreme bitterness of CLA. We use Hot Melt Extrusion (HME) to convert CLA and Eudragit E100 into Solid Dispersion (SD).

View Article and Find Full Text PDF

Background: Candesartan cilexetil (CC) is a selective angiotensin II receptor antagonist widely used to treat hypertension. CC is a substrate of P-glycoprotein (P-gp), causing its efflux to the intestinal lumen. It is also practically insoluble in water and has low oral bioavailability (14%).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore how nanocomposites made from Eudragit E100, nanozinc oxide, and nanochitosan can mask the bitter taste of Paracetamol granules sized between 250-850 µm.
  • Various formulas with different concentrations of these nanocomposites were applied to test their effectiveness in taste masking and drug release behavior in a simulated oral environment.
  • Results showed that the granules coated with 5% nanochitosan provided the best bitter taste masking, with significantly lower drug release rates compared to those coated with nanozinc oxide, indicating better taste covering capabilities of nanochitosan.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!